CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 76 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2019. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $5,293,000 | +20.2% | 58,000 | 0.0% | 3.57% | +16.3% |
| Q4 2018 | $4,403,000 | -31.2% | 58,000 | -27.5% | 3.07% | +28.6% |
| Q3 2018 | $6,400,000 | -99.3% | 80,000 | +823.1% | 2.39% | +495.8% |
| Q2 2018 | $860,794,000 | +49801.1% | 8,666 | -59.3% | 0.40% | -51.6% |
| Q1 2018 | $1,725,000 | -23.7% | 21,301 | -25.8% | 0.83% | -24.5% |
| Q4 2017 | $2,261,000 | -8.9% | 28,701 | +6.7% | 1.10% | -23.0% |
| Q3 2017 | $2,482,000 | – | 26,901 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEW SILK ROAD INVESTMENT PTE LTD | 189,395 | $17,476,000 | 9.13% |
| VERNIER CAPITAL PARTNERS, LP | 122,600 | $11,312,000 | 8.31% |
| RUDMAN ERROL M | 26,901 | $2,482,000 | 1.42% |
| HERMES INVESTMENT MANAGEMENT LTD | 712,424 | $65,735,000 | 0.99% |
| Hillhouse Capital Management | 618,391 | $57,059,000 | 0.94% |
| COMGEST GLOBAL INVESTORS S.A.S. | 356,252 | $32,872,000 | 0.76% |
| CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. | 363,190 | $33,511,000 | 0.26% |
| FIL Ltd | 914,848 | $84,413,000 | 0.24% |
| Gideon Capital Advisors, Inc. | 2,494 | $230,000 | 0.23% |
| WASATCH ADVISORS LP | 137,482 | $12,685,000 | 0.17% |